An Opioid Agonist that Does Not Induce μ-Opioid Receptor—Arrestin Interactions or Receptor Internalization
- 1 February 2007
- journal article
- Published by Elsevier in Molecular Pharmacology
- Vol. 71 (2) , 549-557
- https://doi.org/10.1124/mol.106.028258
Abstract
G protein-coupled receptor desensitization and trafficking are important regulators of opioid receptor signaling that can dictate overall drug responsiveness in vivo. Furthermore, different μ-opioid receptor (μOR) ligands can lead to varying degrees of receptor regulation, presumably because of distinct structural conformations conferred by agonist binding. For example, morphine binding produces a μOR with low affinity for β-arrestin proteins and limited receptor internalization, whereas enkephalin analogs promote robust trafficking of both β-arrestins and the receptors. Here, we evaluate μOR trafficking in response to activation by a novel μ-selective agonist derived from the naturally occurring plant product, salvinorin A. It is interesting that this compound, termed herkinorin, does not promote the recruitment of β-arrestin-2 to the μOR and does not lead to receptor internalization. Moreover, whereas G protein-coupled receptor kinase overexpression can promote morphine-induced β-arrestin interactions and μOR internalization, such manipulations do not promote herkinorin-induced trafficking. Studies in mice have shown that β-arrestin-2 plays an important role in the development of morphine-induced tolerance, constipation, and respiratory depression. Therefore, drugs that can activate the receptor without recruiting the arrestins may be a promising step in the development of opiate analgesics that distinguish between agonist activity and receptor regulation and may ultimately lead to therapeutics designed to provide pain relief without the adverse side effects normally associated with the opiate narcotics.Keywords
This publication has 43 references indexed in Scilit:
- Arrestin Serves as a Molecular Switch, Linking Endogenous α2-Adrenergic Receptor to SRC-dependent, but Not SRC-independent, ERK ActivationJournal of Biological Chemistry, 2006
- Morphine Side Effects in β-Arrestin 2 Knockout MiceThe Journal of Pharmacology and Experimental Therapeutics, 2005
- Morphine Promotes Rapid, Arrestin-Dependent Endocytosis of μ-Opioid Receptors in Striatal NeuronsJournal of Neuroscience, 2005
- Receptor Endocytosis Counteracts the Development of Opioid ToleranceMolecular Pharmacology, 2005
- Salvinorin A, an Active Component of the Hallucinogenic Sage Salvia divinorum Is a Highly Efficacious κ-Opioid Receptor Agonist: Structural and Functional ConsiderationsThe Journal of Pharmacology and Experimental Therapeutics, 2004
- Multifaceted roles of β-arrestins in the regulation of seven-membrane-spanning receptor trafficking and signallingBiochemical Journal, 2003
- μ-Opioid Receptors Desensitize Less Rapidly than δ-Opioid Receptors Due to Less Efficient Activation of ArrestinPublished by Elsevier ,2002
- Classical and new roles of β-arrestins in the regulation of G-PROTEIN-COUPLED receptorsNature Reviews Neuroscience, 2001
- Molecular Determinants Underlying the Formation of Stable Intracellular G Protein-coupled Receptor-β-Arrestin Complexes after Receptor Endocytosis*Journal of Biological Chemistry, 2001
- Threonine 180 Is Required for G-protein-coupled Receptor Kinase 3- and β-Arrestin 2-mediated Desensitization of the μ-Opioid Receptor in Xenopus OocytesPublished by Elsevier ,2001